G. Sassolas

1.4k total citations
51 papers, 1.1k citations indexed

About

G. Sassolas is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, G. Sassolas has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in G. Sassolas's work include Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (19 papers) and Neuroendocrine Tumor Research Advances (8 papers). G. Sassolas is often cited by papers focused on Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (19 papers) and Neuroendocrine Tumor Research Advances (8 papers). G. Sassolas collaborates with scholars based in France, Italy and Belgium. G. Sassolas's co-authors include Bruno Claustrat, D. C. Jordan, Jocelyne Brun, G Chazot, Jacqueline Trouillas, C Girod, Françoise Borson‐Chazot, Richard A. Cohen, Catherine Lombard‐Bohas and Y. Khalfallah and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Pharmaceutical Sciences and The Journal of Pathology.

In The Last Decade

G. Sassolas

50 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Sassolas France 19 595 261 221 220 143 51 1.1k
Richard I. Dorin United States 23 815 1.4× 98 0.4× 110 0.5× 142 0.6× 89 0.6× 49 1.7k
Caroline Sievers Germany 25 902 1.5× 119 0.5× 61 0.3× 203 0.9× 62 0.4× 46 1.4k
G. M. Besser United Kingdom 17 470 0.8× 96 0.4× 158 0.7× 146 0.7× 22 0.2× 39 912
Masahiko Sone Japan 25 361 0.6× 70 0.3× 308 1.4× 372 1.7× 79 0.6× 55 1.7k
Zenei Arihara Japan 19 268 0.5× 52 0.2× 271 1.2× 295 1.3× 87 0.6× 32 1.0k
J.‐G. Ljunggren Sweden 12 676 1.1× 37 0.1× 143 0.6× 90 0.4× 16 0.1× 24 1.1k
Paul E. Cooper Canada 12 219 0.4× 175 0.7× 70 0.3× 146 0.7× 39 0.3× 33 1.2k
C. ROWAN DEBOLD United States 20 904 1.5× 67 0.3× 153 0.7× 138 0.6× 31 0.2× 26 1.5k
Rolf Larisch Germany 23 690 1.2× 46 0.2× 49 0.2× 73 0.3× 35 0.2× 63 1.4k
M O Thorner United States 15 438 0.7× 33 0.1× 239 1.1× 61 0.3× 15 0.1× 20 751

Countries citing papers authored by G. Sassolas

Since Specialization
Citations

This map shows the geographic impact of G. Sassolas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Sassolas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Sassolas more than expected).

Fields of papers citing papers by G. Sassolas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Sassolas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Sassolas. The network helps show where G. Sassolas may publish in the future.

Co-authorship network of co-authors of G. Sassolas

This figure shows the co-authorship network connecting the top 25 collaborators of G. Sassolas. A scholar is included among the top collaborators of G. Sassolas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Sassolas. G. Sassolas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raverot, Gérald, Alain Calender, Jacqueline Trouillas, et al.. (2007). Familial pituitary adenomas with a heterogeneous functional pattern: Clinical and genetic features. Journal of Endocrinological Investigation. 30(9). 787–790. 4 indexed citations
2.
Delgrange, Etienne, et al.. (2005). Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance. Acta Neurochirurgica. 147(7). 751–758. 53 indexed citations
3.
Giammarile, Francesco, et al.. (2004). Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans. European Journal of Endocrinology. 150(3). 277–283. 15 indexed citations
5.
Khalfallah, Y., G. Sassolas, Françoise Borson‐Chazot, N. Véga, & Hubert Vidal. (2001). Expression of insulin target genes in skeletal muscle and adipose tissue in adult patients with growth hormone deficiency: effect of one year recombinant human growth hormone therapy. Journal of Endocrinology. 171(2). 285–292. 17 indexed citations
6.
Sassolas, G., I Bachelot, P. Chanson, et al.. (1999). GH deficiency in adults: an epidemiological approach. European Journal of Endocrinology. 141(6). 595–600. 29 indexed citations
7.
Bornet, H, et al.. (1999). Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating thyroglobulin in thyroid diseases. European Journal of Endocrinology. 140(5). 457–467. 14 indexed citations
8.
Lumbroso, Serge, Jean‐Marc Lobaccaro, Christophe Vial, et al.. (1997). Molecular Analysis of the Androgen Receptor Gene in Kennedy’s Disease. Hormone Research. 47(1). 23–29. 12 indexed citations
9.
Cathébras, P., et al.. (1996). Hypercalcémie induite par la lactation chez deux patientes hypoparathyroïdiennes traitées. La Revue de Médecine Interne. 17(8). 675–676. 7 indexed citations
10.
Sassolas, G.. (1994). Potential Therapeutic Applications of Growth Hormone in Adults. Hormone Research. 42(1-2). 72–78. 5 indexed citations
11.
Persiani, Stefano, G. Sassolas, G. Piscitelli, et al.. (1994). Pharmacodynamics and Relative Bioavailability of Cabergoline Tablets vs Solution in Healthy Volunteers. Journal of Pharmaceutical Sciences. 83(10). 1421–1424. 21 indexed citations
12.
Chanson, P., N. Lahlou, A Warnet, et al.. (1994). Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas. Journal of Endocrinological Investigation. 17(2). 91–98. 12 indexed citations
13.
Trouillas, Jacqueline, G. Sassolas, B Loras, et al.. (1991). Somatotrpic Adenomas without Acromegaly. Pathology - Research and Practice. 187(8). 943–949. 34 indexed citations
14.
Perrin, Gilles, et al.. (1991). Surgical Outcome and Pathological Effects of Bromocriptine Preoperative Treatment in Prolactinomas. Pathology - Research and Practice. 187(5). 587–592. 10 indexed citations
15.
Khalfallah, Y., et al.. (1990). Effects of a New Prolactin Inhibitor, CV 205–502, in the Treatment of Human Macroprolactinomas*. The Journal of Clinical Endocrinology & Metabolism. 71(2). 354–359. 18 indexed citations
16.
Chatelain, Pierre, et al.. (1990). Assay of Growth Hormone Levels in Human Plasma using Commercial Kits: Analysis of Some Factors Influencing the Results. Acta Paediatrica. 79(s370). 56–61. 29 indexed citations
17.
Sassolas, G., et al.. (1989). Effects of the Somatostatin Analog BIM 23014 on the Secretion of Growth Hormone, Thyrotropin, and Digestive Peptides in Normal Men. The Journal of Clinical Endocrinology & Metabolism. 68(2). 239–246. 37 indexed citations
18.
20.
Loras, B, et al.. (1985). [GRF and human somatotropic adenoma. In vivo and in vitro correlations between GH release and morphological and immunocytochemical aspects].. PubMed. 46(6). 373–82. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026